Loading clinical trials...
Loading clinical trials...
The primary objectives of the study are to evaluate the safety and the efficacy in patients with malignant lymphoma or acute leukemia who are repeatedly administered for SR29142 5 days in two dosage g...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi
NCT06197672 · Acute Myeloid Leukemia
NCT07400029 · Acute Lymphoblastic Leukemia
NCT06285890 · Acute Myeloid Leukemia
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT07216443 · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and more
Sanofi-Aventis
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions